spironolactone has been researched along with bumetanide in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (28.57) | 18.7374 |
1990's | 2 (9.52) | 18.2507 |
2000's | 5 (23.81) | 29.6817 |
2010's | 8 (38.10) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Atherton, JC; Green, R; Higgins, A; Large, A; McNicholas, C; Parker, D; Pempkowiak, L; Rajani, K; Smith, J | 1 |
Basile, AS; Lueddens, HW; Skolnick, P | 1 |
Broor, SL; Mishra, SP; Sachdev, G; Sarin, SK; Shrivastwa, A; Sundaram, KR; Talukdar, V | 1 |
Beermann, B | 1 |
Boyer, TD; Warnock, DG | 1 |
Davies, IB; Lightman, SL | 1 |
Alexander, F | 1 |
Donker, AJ; Nauta, JJ; van Vliet, AA; Verheugt, FW | 1 |
Cobbs, S; Jiang, G; Klein, JD; O'Neill, WC | 1 |
Dupont, M; Mullens, W; Nijst, P; Penders, J; Tang, WH; Verbrugge, FH | 1 |
Gravenstein, N; Martynyuk, AE; Seubert, CN; Sumners, C; Tan, S; Vasilopoulos, T; Xu, C; Zhang, J | 1 |
Gravenstein, N; Martynyuk, AE; Puentes, DL; Seubert, CN; Xu, C; Zhang, J | 1 |
3 review(s) available for spironolactone and bumetanide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Aspects on pharmacokinetics of some diuretics.
Topics: Amiloride; Bendroflumethiazide; Bumetanide; Chlorthalidone; Diuretics; Furosemide; Humans; Hydrochlorothiazide; Kinetics; Sodium Chloride Symporter Inhibitors; Spironolactone | 1984 |
Refractory oedema.
Topics: Aminophylline; Bumetanide; Diuretics; Drug Therapy, Combination; Edema; Edema, Cardiac; Ethacrynic Acid; Female; Furosemide; Humans; Liver Cirrhosis; Lymphedema; Nephrotic Syndrome; Protein Deficiency; Renal Dialysis; Spironolactone | 1980 |
2 trial(s) available for spironolactone and bumetanide
Article | Year |
---|---|
Bumetanide, spironolactone and a combination of the two, in the treatment of ascites due to liver disease. A prospective, controlled, randomized trial.
Topics: Administration, Oral; Adult; Ascites; Bumetanide; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Combinations; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Potassium; Prospective Studies; Random Allocation; Sodium; Spironolactone | 1988 |
Use of diuretics in the treatment of cirrhotic ascites.
Topics: Ascites; Bumetanide; Diuresis; Diuretics; Dose-Response Relationship, Drug; Furosemide; Humans; Kidney; Liver Cirrhosis; Natriuresis; Sodium; Spironolactone; Sulfonamides | 1983 |
16 other study(ies) available for spironolactone and bumetanide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Lithium clearance in healthy humans: effects of sodium intake and diuretics.
Topics: Amiloride; Benzothiadiazines; Bumetanide; Diuretics; Furosemide; Humans; Lithium; Metabolic Clearance Rate; Reference Values; Sodium Chloride Symporter Inhibitors; Sodium, Dietary; Spironolactone | 1990 |
Regulation of renal peripheral benzodiazepine receptors by anion transport inhibitors.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; Acetazolamide; Amiloride; Animals; Anions; Anthracenes; Biological Transport; Bumetanide; Furosemide; Hydrochlorothiazide; Kidney; Kinetics; Male; Myocardium; Ouabain; Rats; Rats, Inbred Strains; Receptors, GABA-A; Spironolactone | 1988 |
The effect of ethacrynic acid, bumetanide, frusemide, spironolactone and ADH on electrolyte excretion in ponies.
Topics: Animals; Body Water; Bumetanide; Chlorides; Diuretics; Electrolytes; Ethacrynic Acid; Furosemide; Horses; Male; Potassium; Sodium; Spironolactone; Vasopressins | 1982 |
Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Bumetanide; Drug Resistance; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Renin-Angiotensin System; Spironolactone; Water-Electrolyte Balance | 1993 |
Aldosterone regulates the Na-K-2Cl cotransporter in vascular smooth muscle.
Topics: Adrenalectomy; Aldosterone; Animals; Aorta; Bumetanide; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Phenylephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rubidium Radioisotopes; Sodium-Potassium-Chloride Symporters; Spironolactone; Time Factors; Vasoconstrictor Agents | 2003 |
Urinary composition during decongestive treatment in heart failure with reduced ejection fraction.
Topics: Administration, Oral; Aged; Biomarkers; Bumetanide; Chlorides; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Heart Ventricles; Humans; Injections, Intravenous; Male; Sodium; Spironolactone; Stroke Volume; Treatment Outcome; Urinalysis; Urination; Vasodilator Agents | 2014 |
Anesthesia with sevoflurane in neonatal rats: Developmental neuroendocrine abnormalities and alleviating effects of the corticosteroid and Cl(-) importer antagonists.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Animals, Newborn; Anxiety; Bumetanide; CA1 Region, Hippocampal; Chloride Channels; Corticosterone; Excitatory Postsynaptic Potentials; Female; Male; Maternal Deprivation; Methyl Ethers; Neurosecretory Systems; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Reflex, Startle; Sevoflurane; Sex Characteristics; Spironolactone | 2015 |
Role of Steroids in Hyperexcitatory Adverse and Anesthetic Effects of Sevoflurane in Neonatal Rats.
Topics: Anesthetics; Animals; Animals, Newborn; Brain Waves; Bumetanide; Drug Interactions; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Hippocampus; In Vitro Techniques; Male; Membrane Potentials; Methyl Ethers; Rats; Rats, Sprague-Dawley; Reaction Time; Reflex, Righting; Sevoflurane; Sodium Potassium Chloride Symporter Inhibitors; Spironolactone; Steroids | 2016 |